Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Fibrous Proteins00:55

Fibrous Proteins

Fibrous proteins are either long and narrow proteins or assemble to form long and thin structures. They contain repetitive units and usually consist of either alpha helices or beta sheets and, in rare cases, a mix of both. The amino acids in the primary structure often consist of repeating amino acid sequences. The role of fibrous proteins is primarily structural. Many are located in the extracellular matrix and are present in connective tissues to impart strength and joint mobility. They are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade.

Cellular and molecular life sciences : CMLS·2026
Same author

Combining bacterial display and protein language models to engineer a CD69-binding affibody for molecular imaging of immune activation.

Protein engineering, design & selection : PEDS·2026
Same author

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal of biological engineering·2026
Same author

HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to predict targeted-therapy response in HER2-expressing metastatic breast cancer: study protocol of a multicenter, prospective, open-label trial.

Frontiers in oncology·2026
Same author

Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.

Protein engineering, design & selection : PEDS·2026
Same author

Increased affinity by dimerization of radiolabeled Affibody molecule ATH001 targeting PDGFRβ.

EJNMMI radiopharmacy and chemistry·2026

Related Experiment Video

Updated: May 31, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
11:13

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules

Published on: August 19, 2015

Non-immunoglobulin based protein scaffolds.

John Löfblom1, Fredrik Y Frejd, Stefan Ståhl

  • 1Division of Molecular Biotechnology, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Center, SE-106 91 Stockholm, Sweden.

Current Opinion in Biotechnology
|July 6, 2011
PubMed
Summary

Alternative protein scaffolds offer advantages over traditional antibodies for next-generation immunotherapeutics and molecular imaging. These biologics show promise in clinical development due to their unique properties and improved performance.

More Related Videos

Interlinked Macroporous 3D Scaffolds from Microgel Rods
07:32

Interlinked Macroporous 3D Scaffolds from Microgel Rods

Published on: June 16, 2022

ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly
16:33

ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly

Published on: April 17, 2014

Related Experiment Videos

Last Updated: May 31, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
11:13

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules

Published on: August 19, 2015

Interlinked Macroporous 3D Scaffolds from Microgel Rods
07:32

Interlinked Macroporous 3D Scaffolds from Microgel Rods

Published on: June 16, 2022

ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly
16:33

ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly

Published on: April 17, 2014

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Immunotherapy and Medical Imaging

Background:

  • Non-immunoglobulin based protein scaffolds have emerged as key alternatives to monoclonal antibodies.
  • These novel biologics are increasingly recognized as next-generation immunotherapeutics.
  • A decade of research highlights their potential, with several candidates in clinical development.

Purpose of the Study:

  • To review recent advancements in the application of alternative protein scaffolds.
  • To highlight their use in both therapeutic strategies and medical imaging.
  • To discuss the properties that make these scaffolds advantageous over traditional antibodies.

Main Methods:

  • Review of current scientific literature on non-immunoglobulin based protein scaffolds.
  • Analysis of preclinical and clinical development data for these novel biologics.
  • Comparative assessment of scaffold properties versus monoclonal antibodies.

Main Results:

  • Alternative protein scaffolds possess distinct advantages, including small size, cysteine-free sequences, and tunable pharmacokinetics.
  • Their modular nature facilitates the creation of multispecific molecules for targeted therapies.
  • Several scaffolds demonstrate superior performance in molecular imaging applications compared to full-length antibodies.

Conclusions:

  • Non-immunoglobulin based protein scaffolds are transitioning from research concepts to viable therapeutic and diagnostic agents.
  • Their unique characteristics position them as a significant advancement in immunotherapeutics and molecular imaging.
  • Continued development is expected to yield further clinical and imaging applications.